News Feed Opinion Blog Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Leo Mascarenhas: Elective Discontinuation of Larotrectinib in Pediatric Patients with TRK Fusion Sarcomas
Leo Mascarenhas/cedars-sinai.org
Jan 29, 2025, 12:53

Leo Mascarenhas: Elective Discontinuation of Larotrectinib in Pediatric Patients with TRK Fusion Sarcomas

Leo Mascarenhas, Division Chief and Director of Pediatric Hematology and Oncology at Cedars-Sinai Guerin Children, shared an article on LinkedIn:

“Hot of the press!

Some insight into the implications of stopping treatment in young sarcoma patients!”

Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.

Authors: Leo Mascarenhas, et al.

Leo Mascarenhas: Elective Discontinuation of Larotrectinib in Pediatric Patients with TRK Fusion Sarcomas

cancer Cedars-Sinai Guerin Children fight against cancer Global fight against cancer Hematology larotrectinib Leo Mascarenhas Mesenchymal Tumors OncoDaily Oncology
Special Coverage
Insight
Aug 11, 2025, 14:08
Cecilia Pompili: Do Women and Underrepresented Minorities Recover Differently After Lung Cancer Surgery?
Voices
Aug 11, 2025, 14:05
Honoured to Welcome Yinyan Wang - Mark Hughes Foundation Centre for Brain Cancer Research
Science
Aug 11, 2025, 13:46
Wolfgang Miesbach: CRISPR’s Hidden Danger - Precision Enhancers May Cause Genomic Chaos
Voices
Aug 11, 2025, 13:30
Matthew Smeltzer: Taking Some Time for IASLC Collaborations at JSM25
Voices
Aug 11, 2025, 13:09
Applications Are Open for ESO's Fellowship Programme for Doctors
Science
Aug 11, 2025, 12:48
Myeloma Paper of the Day, August 11th, Suggested by Robert Orlowski
Insight
Aug 11, 2025, 12:38
The Dorcas Cancer Foundation: From Just One child a Decade Ago to Over 100 Children Today
Insight
Aug 11, 2025, 12:32
Cuomo’s Paradox Fundamentally Changes How We Understand Health
Opinion
Aug 11, 2025, 12:27
Norman Ng: Does Hong Kong Need to Establish a "Cancer Drug Formulary"?
Voices
Aug 11, 2025, 12:26
Miriam Mutebi: Launching the Africa Journal of Cancer Research to Amplify African Oncology Innovation
Drugs
Aug 11, 2025, 12:23
Ashley Love Sumrall: First FDA-approved Treatment for H3K27M Diffuse Midline Glioma
Voices
Aug 11, 2025, 12:21
Viktor Simunovic: 5 Ways AI will Shape Personalized Medicine